What is Dr. Harvey?
Dr. Harvey operates as a specialized provider of premium, natural pet food and health-focused products, catering to a discerning demographic of pet owners. With a legacy spanning over three decades, the company distinguishes itself through a rigorous focus on complete recipes, base mixes, and functional herbal supplements for dogs, cats, and birds. By prioritizing ingredient integrity and manufacturing excellence within the USA, Dr. Harvey has established a defensible niche in the competitive pet care market, emphasizing long-term health outcomes over mass-market convenience.
How much funding has Dr. Harvey raised?
Dr. Harvey has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Dr. Harvey
PPP
Public-Private Partnership
What's next for Dr. Harvey?
With the infusion of this late-stage capital, Dr. Harvey is poised to transition into a phase of aggressive market scaling and product diversification. The strategic roadmap likely involves expanding distribution channels to capture a broader share of the health-conscious pet owner segment while potentially investing in R&D to further innovate its functional treat and supplement lines. As the company matures, the focus will shift toward optimizing supply chain efficiencies and reinforcing brand equity to maintain its leadership in the natural pet nutrition space.
See full Dr. Harvey company page
